Results 281 to 290 of about 5,023,895 (307)
Some of the next articles are maybe not open access.
Seminars in Oncology, 2001
Abstract The electrolyte abnormalities and metabolic derangements associated with ATLS are a serious consequence in patients with both hematologic malignancies and solid tumors. While concern is primarily for those with highly proliferative hematopoietic disorders following treatment with exquisitely responsive chemotherapy, the practitioner should ...
openaire +2 more sources
Abstract The electrolyte abnormalities and metabolic derangements associated with ATLS are a serious consequence in patients with both hematologic malignancies and solid tumors. While concern is primarily for those with highly proliferative hematopoietic disorders following treatment with exquisitely responsive chemotherapy, the practitioner should ...
openaire +2 more sources
Overview of tumor lysis syndrome
Seminars in Oncology Nursing, 2002To provide a general overview of tumor lysis syndrome (TLS) focusing on the incidence, epidemiology, and patient outcomes associated with the syndrome; review the role of the oncology nurse in impacting patient outcomes and identify evolving issues relating to TLS.Primary and tertiary literature related to TLS and clinical practice experience.Issues ...
openaire +2 more sources
Incidence and Pathogenesis of Tumor Lysis Syndrome
2004Tumor lysis syndrome (TLS) is a constellation of metabolic disturbances that may be observed in patients with malignancies. Clinically significant TLS can occur spontaneously, but most often is seen 48-72 h after initiation of cancer treatment.
LOCATELLI F, ROSSI, Francesca
openaire +4 more sources
JAMA: The Journal of the American Medical Association, 1983
To the Editor.— The recent report by Vogelzang et al (1983;249:513) of tumor lysis syndrome after chemotherapy for small-cell bronchogenic carcinoma was of great interest. We would like to report an additional case recently seen in our facility. Report of a Case.— A 78-year-old man was found to have small-cell carcinoma of the lung with multiple ...
openaire +1 more source
To the Editor.— The recent report by Vogelzang et al (1983;249:513) of tumor lysis syndrome after chemotherapy for small-cell bronchogenic carcinoma was of great interest. We would like to report an additional case recently seen in our facility. Report of a Case.— A 78-year-old man was found to have small-cell carcinoma of the lung with multiple ...
openaire +1 more source
Rasburicase for Tumor Lysis Syndrome
American Journal of Therapeutics, 2016Swati, Vishwanathan +3 more
openaire +2 more sources
Gan to kagaku ryoho. Cancer & chemotherapy, 2009
Recently, the ASCO guideline has added TLS. Prevention and recognition of the disease and state are important. Molecular targeting drugs, small molecule tyrosine kinase inhibitors and monoclonal antibodies induced rapid regression of the tumors and carry a risk of TLS.
openaire +1 more source
Recently, the ASCO guideline has added TLS. Prevention and recognition of the disease and state are important. Molecular targeting drugs, small molecule tyrosine kinase inhibitors and monoclonal antibodies induced rapid regression of the tumors and carry a risk of TLS.
openaire +1 more source
Pediatric Oncologic Pharmacy, 2019
Carolina Witchmichen Penteado Schmidt
semanticscholar +1 more source
Carolina Witchmichen Penteado Schmidt
semanticscholar +1 more source
Tumor lysis syndrome: pathogenesis and management
Pediatric Nephrology, 1995Deborah L Jones, R W Chesney
exaly